ConditionTotal Knee Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.
Eligibility criteria
Qualifiers
Patients ≥18 years of age
Patients scheduled an elective primary TKA for a diagnosis of osteoarthritis or inflammatory arthritis using the ROSA Knee System.
Patient is willing to cooperate and follow study protocol and visit schedule
Subject has access to a device is capable of pairing to the Apple Watch, supporting application updates and is compatible with the mymobility App.
Disqualifiers
Patient is pregnant
Patient is unable to provide written consent
Revision TKA
History of prior infection in the affected knee
Trial design
Treatments tested in this trial
- Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design
- Zimmer-Biomet Persona Posterior-Stabilized (PS) Bearing Design
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov